Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03625726Unknown
Open-label trial (3 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Thrombin generation assay (area under the curve/ Endogenous Thrombin Potential) with thrombomodulin at Day 1. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03625726.